Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis.
Radioimmunoassays were used to determine titers of antibody to alkaline protease (AP) and elastase (Ela) produced by Pseudomonas aeruginosa in sera and bronchial secretions, in vitro production of AP and Ela by P. aeruginosa isolates, and occurrence of these enzymes in bronchial secretions from patients with cystic fibrosis. Titers of serum antibodies to AP ranging from 1:10 to 1:545 and to Ela ranging from 1:10 to 1:725 were found in 83%-88% of patients with cystic fibrosis and chronic lung infections due to P. aeruginosa. Antibody titers in liquified bronchial secretions were approximately 10% of the serum titers. Thirty-one (93%) of 34 isolates produced both proteases in vitro in comparable amounts (concentration of protease in culture supernatant: AP, 0.01-480 micrograms/ml; Ela, 0.02-490 micrograms/ml). AP and Ela were detected in vivo when antibodies to the enzymes were absent. The results suggest that specific immune responses in patients with cystic fibrosis neutralize proteases of P. aeruginosa.
D000293:Adolescent; D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis; D001980:Bronchi / Q000201:enzymology / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000201:enzymology / Q000276:immunology / Q000382:microbiology*; D010450:Endopeptidases / Q000276:immunology*; D005260:Female; D006801:Humans; D008297:Male; D010196:Pancreatic Elastase / Q000276:immunology*; D011552:Pseudomonas Infections / Q000201:enzymology / Q000276:immunology; D011550:Pseudomonas aeruginosa / Q000201:enzymology* / Q000276:immunology; D011863:Radioimmunoassay; D012697:Serine Endopeptidases
D000907:Antibodies, Bacterial; D010450:Endopeptidases; D012697:Serine Endopeptidases; D010196:Pancreatic Elastase; C032923:microbial serine proteinases